SIM
MDGL icon

Spark Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Spark Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,800
Closed -$892K – 472
2019
Q4 		$892K Buy
+9,800
New +$950K 0.1% 265
2019
Q3 		– Sell
-7,100
Closed -$744K – 470
2019
Q2 		$744K Buy
+7,100
New +$761K 0.05% 327

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Spark Investment Management's MDGL Position: Q1 2020 in Review

Spark Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2020, closing a stake of 9,800 shares — an estimated $892K sold.

Spark Investment Management first reported a position in MDGL in Q2 2019 and held it in 2 quarters. The position peaked at $892K in Q4 2019. 109 funds tracked by Wall St. Rank hold MDGL as of Q1 2020.

  • Spark Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Spark Investment Management sold 9,800 Madrigal Pharmaceuticals shares in Q1 2020, an estimated $892K.
  • Spark Investment Management first reported a position in Madrigal Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • Spark Investment Management's Madrigal Pharmaceuticals position peaked at $892K in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.